무수정체증 시장 규모, 점유율, 성장 분석 : 유형별, 최종사용자별, 치료법별, 지역별 - 업계 예측(2026-2033년)

Global Aphakia Market size was valued at USD 2 Billion in 2024 and is poised to grow from USD 2.23 Billion in 2025 to USD 5.25 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

The global aphakia market is witnessing significant growth driven by an increase in cataract cases, a rising aging population, and a heightened incidence of eye trauma due to accidents and sports injuries. These factors lead to lens dislocation and necessitate treatment for aphakia. Enhanced lens design innovations contribute to improving treatment outcomes, further boosting demand. Growing public awareness regarding eye health and early intervention also plays a crucial role. Increased healthcare access through government initiatives and mobile clinics facilitates wider treatment adoption. Additionally, the integration of advanced technologies such as AI, machine learning, IoT, and augmented reality is transforming the market by enabling better diagnosis, training for surgeons, and real-time patient monitoring, ultimately improving surgical outcomes and patient satisfaction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aphakia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aphakia Market Segments Analysis

Global Aphakia Market is segmented by Type, End User, Treatment and region. Based on Type, the market is segmented into Acquired Aphakia and Congenital Aphakia. Based on End User, the market is segmented into Hospitals, Ophthalmic clinics and Others. Based on Treatment, the market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation and Refractive Surgery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aphakia Market

The global Aphakia market is significantly influenced by developments in cataract surgery, where the removal of the eye's natural lens creates a growing demand for effective aphakia treatment options. As more healthcare professionals prioritize cataract removal in patients with heightened surgical risks, the market continues to expand. Additionally, improved access to healthcare in various regions is resulting in a higher incidence of aphakia cases, thereby driving market growth. This trend highlights the increasing need for innovative solutions to address the challenges associated with aphakia, fostering opportunities for both established companies and emerging players within the healthcare industry.

Restraints in the Global Aphakia Market

The Global Aphakia market faces significant restraints primarily due to the high costs associated with treatment options. Addressing aphakia typically involves the use of intraocular lenses, specialized contact lenses, or intricate surgical procedures, all of which can be prohibitively expensive. This financial burden limits access to treatment for many patients. Furthermore, manufacturers struggle to strike a balance between maintaining affordability and delivering the precision and safety essential for effective aphakia management. As a result, these economic factors create barriers that hinder the widespread adoption and availability of necessary treatments for individuals affected by this condition.

Market Trends of the Global Aphakia Market

The Global Aphakia market is experiencing robust growth, driven by a heightened demand for intraocular lenses (IOLs) among both patients and ophthalmologists. This rising awareness about the advantages of IOLs is significantly propelling interest in intraocular lens-based surgeries. Additionally, the trend towards minimally invasive procedures, which offer enhanced patient comfort and expedited recovery times, is further fueling the market. Innovations in lens technology and the increasing prevalence of cataracts are contributing to a favorable environment for IOL adoption, leading to a shift in treatment paradigms and transforming the landscape of cataract and aphakia management worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Aphakia Market Size by Type & CAGR (2026-2033)

• Market Overview
• Acquired Aphakia
• Congenital Aphakia

Global Aphakia Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ophthalmic clinics
• Others

Global Aphakia Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Spectacles
• Contact Lenses
• Intraocular Lens Implantation
• Refractive Surgery

Global Aphakia Market Size & CAGR (2026-2033)

• North America (Type, End User, Treatment)
  • US
  • Canada
• Europe (Type, End User, Treatment)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End User, Treatment)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End User, Treatment)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End User, Treatment)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson Vision (Johnson & Johnson Services Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG (ZEISS International)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtec BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperVision Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menicon Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus BioTech AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UltraVision CLPL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations